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Trypanosomatids possess glycosome organelles that contain much of the
glycolytic machinery, including phosphofructokinase (PFK). We present
kinetic and structural data for PFK from three human pathogenic try-
panosomatids, illustrating intriguing differences that may reflect evolution-
ary adaptations to differing ecological niches. The activity of Leishmania
PFK – to a much larger extent than Trypanosoma PFK – is reliant on
AMP for activity regulation, with 1 mM AMP increasing the L. infantum
PFK (LiPFK) kcat/K0.5
F6P value by 10-fold, compared to only a 1.3- and
1.4-fold increase for T. cruzi and T. brucei PFK, respectively. We also
show that Leishmania PFK melts at a significantly lower (> 15 °C) temper-
ature than Trypanosoma PFKs and that addition of either AMP or ATP
results in a marked stabilization of the protein. Sequence comparisons of
Trypanosoma spp. and Leishmania spp. show that divergence of the two
genera involved amino acid substitutions that occur in the enzyme’s ‘reach-
ing arms’ and ‘embracing arms’ that determine tetramer stability. The dra-
matic effects of AMP on Leishmania activity compared with the
Trypanosoma PFKs may be explained by differences between the T-to-R
equilibria for the two families, with the low-melting Leishmania PFK
favouring the flexible inactive T-state in the absence of AMP. Sequence
comparisons along with the enzymatic and structural data presented here
also suggest there was a loss of AMP-dependent regulation in Trypanosoma
species rather than gain of this characteristic in Leishmania species and that
AMP acts as a key regulator in Leishmania governing the balance between
glycolysis and gluconeogenesis.
Introduction
The Trypanosomatida order is comprised of exclusively
parasitic species, including the medically relevant genera
Leishmania and Trypanosoma. Trypanosomatids are
unique in possessing glycosomes, specialized membrane-
bounded metabolic organelles related to peroxisomes
[1–3]. Each parasite contains multiple glycosomes, with
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bloodstream-form T. brucei possessing approximately
65 glycosomes per cell, each with a diameter about
0.3 µm, comprising 4–5% of the total cell volume [4].
The majority of the glycolytic and gluconeogenic path-
way enzymes are sequestered in the glycosomes along
with some other metabolic enzymes. The functions of
the glycosomes, and the possible evolutionary drivers
for its origin, have been the subject of much debate
[2,3]. The singular nature of trypanosomatid metabo-
lism caused these pathogens – particularly T. brucei – to
be extensively studied [5].
Glycosomes contain phosphofructokinase (PFK),
which catalyses the third step of glycolysis: the phos-
phorylation of fructose 6-phosphate (F6P) to fructose
1,6-bisphosphate (F16BP) via the conversion of ATP
to ADP. This reaction involves a large negative free
energy change and is the first committed step of gly-
colysis. Trypanosomatid PFKs, notably the enzyme of
T. brucei (TbPFK), have been studied in great detail
[6–19]. They have high overall amino acid sequence
identities (Table 1), with complete conservation of sub-
strate binding sites for both ATP (first described in
TbPFK crystal structure [6,19]) and F6P (with the F6P
site inferred by comparison with the Escherichia coli
crystal structure [20]), as shown in Fig. S1. Crystal
structures show TbPFK is a tetramer of four 53-kDa
subunits [6,19]. However, there are low amino acid
sequence identities of 23–26% between human PFK
isoforms and the trypanosomatid PFKs [7]. This low
identity is attributed to a complex evolutionary trajec-
tory. Phylogenetic analysis demonstrated that try-
panosomatid PFKs are evolutionarily related to
inorganic pyrophosphate-dependent PFKs (PPi-PFK;
EC 2.7.1.90), while all known metazoan PFKs belong
to the ATP-dependent PFKs (ATP-PFK; EC 2.7.1.11).
These two groups are homologous, yet have a very dis-
tant common ancestral enzyme [7]. Nonetheless, try-
panosomatid PFKs exclusively use ATP as a phospho-
donor, indicating that they must have undergone a
change in phospho-donor specificity during their evo-
lution [6,7]. This ancestry also explains differences in
the active site when comparing the T. brucei PFK
crystal structure on the one hand with authentic PPi-
PFKs and on the other hand with ATP-PFKs [6,19].
Furthermore, the activity of trypanosomatid PFKs is
not regulated by any of the common regulators of
well-studied bacterial, yeast, plant and mammalian
ATP-PFKs [8–18,20,21]. This may be due in part to
the different ancestry, but also to adaptation to the
unique compartmentation of trypanosomatid PFKs
within glycosomes [1–3].
Many Trypanosomatida are monoxenous (one host)
insect parasites, with Leishmania, Phytomonas and
Trypanosoma being the only dixenous (two hosts) gen-
era within the order. Phylogenetic trees indicate diver-
gence between the Leishmania and Trypanosoma
genera occurred around 120 million years ago, with a
subsequent split occurring between salivarian and ster-
corarian Trypanosoma species, represented by the Afri-
can T. brucei and American T. cruzi, respectively,
approximately 100 million years ago [22,23]. T. brucei
lives in extracellular fluids only, with no intracellular
stage; in the human host, T. brucei is highly glucose-
dependent, exhibiting a very high glycolytic flux [2],
though not in the tsetse fly stages, where proline and
other amino acids are the main sources for ATP pro-
duction [24]. T. cruzi has an intracellular stage as
amastigotes in the cytosol of a variety of cell types,
and conflicting information exists about the use of glu-
cose by amastigotes; its intracellular concentration in
host cells is usually scarce, and the parasite glucose
transporter was shown to be downregulated [12]. How-
ever, a recent publication reported that restriction of
extracellular glucose impaired amastigote proliferation
and that intracellular T. cruzi amastigotes capitalize
on the host metabolic response to parasite infection by
increasing glucose uptake to fuel their own metabolism
and replication in the host cytosol [25]. In contrast,
sugars are probably also limited for the insect epi-
mastigote forms [26]. Leishmania spp. are even more
specialized, only transforming from the extracellular
promastigotes in the sandfly into amastigotes inside
Table 1. Trypanosomatid PFK amino acid sequences share high percentage sequence identities. Amino acid sequences were retrieved
from www.uniprot.org; alignments made using CLUSTAL OMEGA 2.1a.
L. mexicana L. infantum L. donovani T. brucei T. cruzi
L. mexicana 100% 98% 97% 70% 71%
L. infantum 100% 100% 70% 72%
L. donovani 100% 70% 72%
T. brucei 100% 77%
T. cruzi 100%
a http://www.ebi.ac.uk/Tools/msa/clustalo/.
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the phagolysosome of mononuclear phagocytes. It was
previously assumed that glycolysis was unimportant in
this low-sugar environment, but it has recently been
shown that L. mexicana is reliant on glycolysis in acti-
vated macrophages [27]. The concentrations of glucose
and other saccharides in each of these environments
are very different, and trypanosomatid PFKs will have
evolved different kinetic properties to adapt to their
respective habitats.
Here, we present a comparison of the enzyme kinetic
and structural differences of heterologously expressed,
fully purified recombinant PFKs of three disease-caus-
ing trypanosomatid species. No data have previously
been published on Leishmania infantum PFK (LiPFK),
although data are available on other, closely related
(Table 1) leishmanial PFKs [8,9]. Reports of the
kinetic properties of T. cruzi PFK (TcPFK) and
TbPFK have been previously published (references sta-
ted in Table 2), though these have never been directly
compared to each other, or with any leishmanial PFK
[8–18]. AMP is a long-recognized allosteric activator
of TbPFK [16], and the X-ray structure of TbPFK in
complex with AMP presented here provides new
insight into the reaction ordering and allosteric
mechanisms of these enzymes and, together with the
kinetic data, offers an intriguing perspective on the
evolution of metabolic regulation as adaptation to the
respective environments of these parasites.
Results
PFK activity differs between trypanosomatid
species
Values of kinetic parameters of all three trypanoso-
matid PFKs were determined for ATP and F6P, with
and without AMP (Figs 1 and 2, Table 3). TcPFK has
a lower affinity for ATP (K0.5
ATP 94.6 lM) compared
to other trypanosomatid PFKs, with TbPFK and
LiPFK having similar values (K0.5
ATP 50.4 and
49.6 lM, respectively). In contrast, TcPFK and
TbPFK have similar affinities for F6P (K0.5
F6P 310
and 365 lM, respectively), but LiPFK has a signifi-
cantly lower affinity, at almost an order of magnitude
less (K0.5
F6P 2886 lM). Comparison of the resulting fits
with F-tests (data not shown) indicates that ATP binds
with a small degree of cooperativity for TcPFK,
TbPFK and LiPFK (h values 1.24, 1.36 and 1.10,
Table 2. Biochemical parameters for trypanosomatid PFKs incorporating all previous studies and the values obtained from this work.
Species Source K0.5
ATP (mM) K0.5
F6P (mM)
Vmax
µmolmin1mg1 Conditions Reference
T. cruzi Partially purified parasite 0.04 1.31 (0.37 if 0.5 mM AMP) 0.4 1 mM ATP
1 mM F6P
[11,18]
Recombinant (E. coli) 0.0125 – – 1 mM F6P [12,19]
Purified parasite 0.025 2.8 0.07 0.5 mM ATP
2 mM F6P
[13,20]
Whole parasite homogenate – 0.29 (epimastigotes)
0.15 (metacyclics)
40.3 1 mM ATP [14,21]
Partially purified parasite 1.9 (0.05 if
3 mM
AMP)
1.75 (0.8 if 0.1 mM AMP) – Not stated [15,22]
Recombinant (E. coli) 0.095 0.31 0.068 3 mM F6P
1.5 mM ATP
This work
T. brucei Purified parasite 0.065 0.999 – 5 mM F6P
1 mM ATP
[16,23]
Recombinant (E. coli) 0.144 1.15 0.045 0.5 mM ATP
1.6 mM AMP
[17,24]
Purified parasite 0.026 0.82 0.267 2 mM ATP [18,25]
Recombinant (E. coli) 0.050 0.37 0.045 3 mM F6P
1.5 mM ATP
This work
L. mexicana Whole parasite homogenate – – 0.138 (promastigotes)
0.089 (amastigotes)
0.4 mM ATP
3.3 mM F6P
[10,17]
L. donovani Recombinant (E. coli) – 3.6 (0.157 if 1.5 mM AMP) Not stated 1 mM ATP [9,16]
Whole parasite homogenate 0.08 10 (0.5 if 3 mM AMP) 0.29
0.43 with 3 mM AMP
Not stated [8,15]
L. infantum Recombinant (E. coli) 0.050 2.89 0.014 3 mM F6P
1.5 mM ATP
This work
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respectively), in contrast to previously published litera-
ture suggesting that the ATP binding curve is hyper-
bolic rather than sigmoidal [18]. F6P binds in a more
cooperative manner (h values 1.78, 1.64 and 1.78,
respectively), in keeping with previous studies
[8,11,18]. These results show that cooperativity of
binding for PFK substrates does not differ greatly
between trypanosomatid species (Table 3).
GTP is an alternative nucleotide substrate
Previous studies have shown that GTP is a possible
alternative phospho-donor for TbPFK [16] and bacte-
rial PFKs [28], though not for LiPFK [8]. The data
presented in Fig. 1 and Table 3 confirm that GTP is
an alternative phospho-donor for TcPFK, TbPFK and
LiPFK (K0.5
GTP 195, 123 and 342 lM, respectively).
An interesting additional observation from running
this assay using human muscle pyruvate kinase (PYK-
M) as one of the linker enzymes (see the Materials and
methods) is that PYK-M can use GDP as a substrate;
no ADP was present in the GTP experiments and
PYK-M was able to use GDP to convert PEP into
pyruvate. This observation is in line with the historical
and little-referenced observation from Hohnadel and
Cooper [29].
The physiological relevance of trypanosomatid
PFKs using GTP as a phospho-donor is uncertain but
probably low. There are several indications that try-
panosomatid glycolysis is generally dependent on
Fig. 1. Kinetic plots of Trypanosoma cruzi
PFK ( , solid blue line), Trypanosoma brucei
PFK ( , dotted red line) and
Leishmania infantum PFK ( , dot-dashed
green line) with respect to ATP titrations (A)
and GTP titrations (B) show different kinetic
properties for each enzyme. Data were
fitted with sigmoidal curves given by the
equation for a cooperative (allosteric) model
(see the Materials and methods) (n = 3;
error bars represent standard deviations;
3 mM F6P).
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ATP, with other nucleoside triphosphates being of
much lesser importance. While the concentrations of
GDP and GTP have not been directly measured within
glycosomes, total cellular concentrations of GTP are
significantly lower than ATP, with a calculated GTP/
ATP ratio of 0.4 [30]. Furthermore, ATP-dependent
enzymes in glycosomes have been experimentally
detected or indirectly identified through possession of
glycosome-targeting motifs, but no glycosomal GTP-
dependent enzymes have been reported. A third point
arguing against the physiological relevance of GTP is
that there must be a mechanism within the glycosomes
for rephosphorylating the resulting GDP for reuse; the
only known glycosomal enzyme that can generate
nucleoside triphosphates at the high rates required is
phosphoglycerate kinase, which is highly specific for
ADP and cannot use other nucleoside diphosphates
including GDP [31].
Fig. 2. Kinetic plots with respect to
fructose 6-phosphate titrations for
Trypanosoma cruzi PFK (TcPFK) ( , blue
line), Trypanosoma brucei PFK (TbPFK) ( ,
dotted red line) and Leishmania infantum
PFK (LiPFK) ( , dot-dashed green line)
show different kinetic properties for each
enzyme. Effects of 1 mM AMP, shown
alongside for TcPFK ( , pale blue line),
YbPFK ( , dotted red line) and LiPFK ( ,
dot-dashed green line) show
disproportionate activation for LiPFK. Data
were fitted with a sigmoidal curve given by
the equation for a cooperative (allosteric)
model (n = 3; error bars represent standard
deviations; 1.5 mM ATP).
Table 3. Kinetic parameters for TcPFK, TbPFK and LiPFK, for main substrates (F6P, ATP) and accessory substrates (GTP), with and without
AMP. Data obtained from minimum n = 3; values are mean averages with standard deviations, and ND indicates not done.
AMP
TcPFK TbPFK LiPFK
0 mM 1 mM 0 mM 1 mM 0 mM 1 mM
F6P
Vmax
F6P (lmolmin1mg1) 71.3 (1.1) 70.9 (1.7) 47.1 (0.7) 30.9 (1.0) 45.1 (2.9) 37.9 (1.3)
K0.5
F6P (lM) 310 (14) 227 (15) 365 (15) 182 (20) 2886 (310) 253 (25)
kcat
F6P (s1) 66.4 (1.0) 66.1 (1.6) 43.8 (0.6) 28.7 (1.0) 42.4 (2.7) 35.6 (1.2)
kcat
F6P/K0.5
F6P (s1lM1) 0.21 0.29 0.12 0.16 0.015 0.14
h (F6P) 1.78 (0.13) 1.90 (0.20) 1.64 (0.09) 1.06 (0.11) 1.78 (0.22) 1.91 (0.32)
ATP
Vmax
ATP (lmolmin1mg1) 68.4 (1.0) 64.8 (1.9) 44.5 (1.4) 27.7 (0.6) 13.6 (0.2) 14.1 (0.2)
K0.5
ATP (lM) 94.6 (4.9) 65.7 (6.1) 50.4 (1.8) 36.9 (2.6) 49.6 (2.8) 51.1 (2.2)
kcat
ATP (s1) 63.7 (1.02) 60.41 (1.75) 41.4 (1.26) 25.7 (0.52) 12.8 (0.21) 13.2 (0.17)
kcat
ATP/K0.5
ATP (s1lM1) 0.67 0.92 0.82 0.70 0.26 0.26
h (ATP) 1.24 (0.06) 1.39 (0.17) 1.36 (0.06) 1.44 (0.16) 1.10 (0.07) 1.08 (0.06)
GTP
Vmax
GTP (lmolmin1mg1) 63.0 (1.8) ND 38.3 (0.9) ND 10.5 (0.7) ND
K0.5
GTP (lM) 195 (14) ND 123 (8) ND 342 (50) ND
kcat
GTP (s1) 58.7 (1.7) ND 35.6 (0.84) ND 9.9 (0.62) ND
kcat
GTP/K0.5
GTP (s1lM1) 0.30 ND 0.29 ND 0.03 ND
h (GTP) 1.38 (0.1) ND 1.5 (0.12) ND 1.27 (0.14) ND
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AMP is the sole known effector of
trypanosomatid PFKs
AMP is a known allosteric activator of all trypanoso-
matid PFKs [8,11,18]. Values of kinetic parameters for
F6P and ATP were determined for all three trypanoso-
matid PFKs in the presence and absence of 1 mM
AMP, as shown in Fig. 2 and Table 3. The addition of
AMP increases the affinity of TcPFK and TbPFK for
ATP, with respective reductions in K0.5 values of
about 30%; no change was seen for LiPFK. Reduc-
tions in Vmax values were observed for TbPFK and, to
a lesser degree, for TcPFK. The reduction in Vmax for
both ATP and F6P (particularly for TbPFK) with a
concomitant reduction in K0.5 is consistent with AMP
acting as an ‘uncompetitive inhibitor’ that only forms
an enzymatically productive complex with PFK after
the substrate (ATP) has bound (see results below on
Reaction Order). No significant changes in Hill coeffi-
cient values were demonstrated.
The effects of AMP on F6P binding are more
marked and are observed in all three trypanosomatid
PFKs. The affinity for F6P of TcPFK and TbPFK
increases significantly in the presence of AMP, with
respective reductions in K0.5 by 27% and 50%. LiPFK
is a special case, with a massive increase in affinity for
F6P shown by a reduction in K0.5 by 91% and a much
improved kcat/K0.5 value, now similar to the other try-
panosomatid PFKs (TcPFK 0.29 s1lM1; TbPFK
0.16 s1lM1; LiPFK 0.14 s1lM1). Measurements
of cooperativity in the presence of AMP showed a sig-
nificant change to a hyperbolic binding model for F6P
binding to TbPFK (Hill coefficient reducing to 1.06
from 1.64). The overall cellular AMP concentration in
bloodstream-form T. brucei has been estimated to vary
between 0.25 and 2.2 mM during its growth [30] and
suggests that the activation effects shown in our
kinetic studies are biologically relevant.
Addition of 0.5 mM GMP had a similar effect to
AMP on both TcPFK and TbPFK (kcat/K0.5
F6P
increases by 33% and 43%, respectively) (data not
shown). The biological relevance of activation by GMP
is unknown. Screening of several common metabolites
at a concentration of 1 mM using fixed substrate concen-
trations (corresponding to the respective K0.75
F6P and
K0.75
ATP values) did not show any significant effects for
any trypanosomatid PFK (data not shown). The
metabolites included ADP, a-ketoglutarate, cyclic
AMP, citrate, fumarate, fructose 2,6-bisphosphate, glu-
cose 6-phosphate, GDP, malate, oxaloacetate, PEP,
PPi, pyruvate and succinate. TcPFK was used as a
screen to investigate the effect of amino acids. All 20
naturally occurring amino acids were tested at 1 mM
concentrations, with none demonstrating significant
effects on TcPFK activity (data not shown).
Reaction order influences kinetic parameters
Altering the sequence of addition of reaction compo-
nents for TbPFK results in marked effects on kinetic
properties. In a separate series of experiments to exam-
ine this effect, we show that when ATP is incubated
with His-tagged TbPFK for 15 min and the reaction is
started by adding F6P, the K0.5
F6P is 596  19 µM.
However, reversing the order and incubating TbPFK
with F6P for 15 min before initiating the reaction with
ATP give a considerably larger K0.5
F6P of
1220  97 µM, suggesting that ATP binds first and
somehow primes the F6P binding site. The Vmax of the
enzyme is unaffected by the reaction order, remaining
at ~ 50 µmolmin1mg1 for both experiments. These
results are consistent with the surface plasmon reso-
nance studies, which could not detect F6P binding
unless ATP was present (Table 4).
The order of binding also seems to play a role in
AMP effector mechanism and binding. Enzyme activ-
ity only appears to be significantly enhanced by AMP
if it is added after the enzyme is incubated with ATP.
Incubating AMP (at a fixed concentration of 0.5 mM)
with PFK for 15 min at room temperature and then
adding ATP followed immediately by F6P to start the
reaction give a specificity constant (kcat/K0.5
F6P) of
0.07 s1lM1 and K0.5F6P of 394  19 µM. Reversing
the order and incubating PFK first with ATP for
15 min and then adding AMP followed by F6P give
an enhanced specificity constant (kcat/K0.5
F6P) of
0.14 s1lM1 and K0.5F6P of 178  17 µM.
Table 4. Steady-state SPR affinities for key ligands for each
trypanosomatid PFK. (N = 3; values are mean averages with
standard errors; surface densities: TbPFK = 3200 RU;
TcPFK = 3100 RU; LiPFK = 1400 RU).
TcPFK TbPFK LiPFK
AMP
Kd
AMP (mM) 1.04 (0.30) 0.47 (0.02) 2.3 (0.20)
Kd
AMP + 1 mM ATP (mM) 1.69 (0.10) 1.93 (0.30) 12.2 (4.80)
ADP
Kd
ADP (mM) 0.73 (0.10) 0.56 (0.08) 0.16 (0.02)
Kd
ADP + 1 mM ATP (mM) 2.13 (0.32) 1.51 (0.11) 0.86 (0.13)
ATP
Kd
ATP (µM) 35.4 (5.6) 15.8 (2.3) 16.8 (2.1)
Kd
ATP + 1 mM AMP (µM) 36.7 (3.3) 15.1 (1.7) 19.3 (1.1)
F6P
Kd
F6P (mm) No binding No binding No binding
Kd
F6P + 1 mM ATP (mM) Weak
binding
Weak
binding
Weak
binding
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Substrate affinities as measured by surface
plasmon resonance
For substrate-affinity measurements by SPR, sensor
chip surfaces of 1400–3200 response units (RU) were
produced for each of the three trypanosomatid PFKs.
A range of substrates and other analytes were tested
against each surface. Steady-state affinities for ligands
(ATP, F6P, AMP and ADP) are shown in Table 4,
alongside selected combinations.
Using AMP titrations as analyte solution showed that
AMP binds to TbPFK with a higher affinity (Kd
AMP
0.47 mM) compared with TcPFK (1.04 mM) and LiPFK
(2.3 mM). The effect of ATP on AMP binding was mea-
sured by including 1 mM ATP in both the running buf-
fer and the AMP analyte solutions. This greatly
weakened the affinity for AMP in both TbPFK
(1.93 mM) and LiPFK (12.2 mM) and, to a lesser extent,
TcPFK (1.69 mM). ADP binds relatively tightly to
TbPFK (Kd
ADP 0.56 mM) and TcPFK (0.73 mM), with
LiPFK having the strongest affinity (0.16 mM). Addi-
tion of 1 mM ATP to the analyte solution decreased
these affinities by three- to fivefold in all three enzymes,
presumably due to competition in the active site
(Table 4). This suggests that ADP binds mainly to the
active site rather than any putative allosteric site.
Measured steady-state affinities for ATP were strong
for TcPFK, TbPFK and LiPFK (Kd
ATP 35.4 µM, 15.8
and 16.8 µM, respectively) (Fig. S2). Addition of 1 mM
AMP to the analyte solution did not significantly
change Kd
ATP (Table 4), Kd
F6P (data not shown) or
Kd
ADP (data not shown), though tethering of the
enzyme to the SPR chip surface may prevent confor-
mational changes necessary for AMP effects. No bind-
ing response was observed for F6P, even at
concentrations of up to 10 mM, against any of the try-
panosomatid PFK surfaces. However, adding 1 mM
ATP to the analyte solution allowed F6P binding to
be observed, though the binding response did not
achieve saturation even at 10 mM F6P (Rmax 5.8 RU
compared to the maximum binding response of 26 RU
for the TbPFK surface). Lack of F6P saturation may
be explained by dynamic movement of PFK while cat-
alysing the conversion of substrates into products, or
by enzyme tethering effects. The difference in F6P
binding with and without ATP strongly suggests that
F6P binding is contingent on ATP binding.
Leishmania PFK melts at a significantly lower
temperature than the Trypanosoma PFKs
T. brucei, T. cruzi and L. infantum PFKs have melting
temperatures (Tm) of 59  0.2, 54  0.2 and
39  0.3 °C, respectively (see the Materials and meth-
ods and Fig. S3). The melting traces for the three try-
panosomatid PFKs show that each protein melts in a
single unfolding event with the rather surprising result
that LiPFK melts 20 °C lower than TbPFK. The effect
of a range of metabolite molecules on PFK melting
temperatures was also tested (Fig. S4). The largest
effect was observed with the effector AMP, which
increased Tm by between 9 °C (LiPFK) and 6 °C
(TbPFK). F6P does not cause a change in the Tm of
any of the trypanosomatid PFKs, a result that is in
line with the SPR data and supports the idea that F6P
does not bind in isolation.
The structure of AMP-bound T. brucei PFK
adopts a compact stable conformation
The crystal structure of T. brucei PFK with bound
AMP contains two tetramers within the asymmetric
unit and has been refined at a resolution of 2.75 A.
The overall subunit architecture (Fig. 3) is very similar
to that described for the apoenzyme and the ATP-
bound forms of T. brucei PFK (PDB 2HIG and
3F5M) [6,19]. The monomer is folded into three
domains: Domain A (residues 8–94 and 410–441),
Domain B (residues 95–233 and 386–409) and Domain
C (residues 234–385 and 442–453) (Fig. 3).
Comparison of the AMP-bound TbPFK structure
with the apo TbPFK (PDB 2HIG) structure shows
that AMP binding in the effector site results in a tight-
ening of the tetramer and a dramatic ordering of the
long helical ‘reaching arms’ (residues 458–486) which
act as clamps anchoring together each pair of diamet-
rically opposite chains in the tetramer (highlighted in
Fig. 3). A similar ordering of the C-terminal ‘reaching
arm’ helices was observed in the ATP-bound structure
(PDB 2HIG), though the helices slide past each other
by a full two helical turns in the AMP structure com-
pared to the ATP structure (Supplementary Movie).
The ‘embracing arms’ (residues Pro63 to Pro79) are
also ordered in the AMP-bound structure with short
stretches of antiparallel b-sheet contributing to stabi-
lization of each dimer (Fig. 3). The ‘inserted loop’
which interacts with ATP is ordered in the ATP-bound
structure (PDB 3F5M) but remains disordered in both
the AMP-bound and apo structures (Fig. 3). A movie
morphing between the apo, ATP-bound and AMP-
bound structures shows the conformational differences
between these three structures (Supplementary Movie).
The AMP effector site is located at the interface
between two monomers, approximately 30 A from the
ATP binding site. AMP forms direct interactions with
pairs of monomers (Figs 3–5) resulting in closure of
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this interface (Figs 4 and 5). Interestingly, the binding
mode of AMP in the T. brucei effector site, is almost
180° rotated from the pose adopted by ADP which
acts as an allosteric activator in the equivalent effector
site of E. coli PFK (PDB 1PFK) which lacks the C-
terminal extended ‘reaching arms’.
The PFK residues that form the allosteric AMP
binding site are generally well conserved (11 out of 17
residues) in all Kinetoplastea analysed. There are,
however, some important amino acid differences
between PFKs from Leishmania and Trypanosoma that
may contribute to differences in the effect of AMP on
enzymatic activity that we have observed. Figure 4
shows the residues contacting AMP in TbPFK with
three key substitutions that distinguish TbPFK from
LiPFK (numbering of LiPFK residue shown in brack-
ets): A396T(394), N125I(123) and T159R(157). The
SPR results suggest that AMP binding to LiPFK is
nearly fivefold weaker than to TbPFK.
Comparison of PFK sequences from Leishmania
and Trypanosoma
The insights from amino acid differences at the AMP
binding site prompted us to see if there were more sys-
tematic differences between species belonging to Leish-
mania and Trypanosoma. Four diverse species from
each genus were selected for comparison, including
three Leishmania from diverse subgroups/complexes
(Leishmania, Sauroleishmania and Viannia) and the
related Endotrypanum (which clusters alongside Leish-
mania in phylogenetic analyses). For Trypanosoma spe-
cies, two salivarian and two stercorarian species were
selected. The amino acid sequence alignment (Fig. S1)
shows 58% of amino acids are completely conserved
between both groups. Of the remaining amino acids,
29% are conserved among the selected four Leishma-
nia species while only 12% are conserved among the
four Trypanosoma species (as highlighted in Fig. S1).
Only 8% of the residues do not show clustering (i.e.
Fig. 3. Overall structure of tetrameric Trypanosoma brucei PFK.
Three of the four monomers are shown faded in the background and
coloured yellow, orange and green. The fourth monomer is coloured
in different shades of red to highlight the different domains. The
ordered ‘embracing’ and ‘reaching’ arms are coloured black and blue,
respectively. (The partner ‘embracing’ arm from the green monomer
is also highlighted to show how the arms intertwine.) The disordered
inserted loop is coloured green and taken from the ATP containing
structure 3F5M [5,24]. ATP (drawn as sticks) is also taken from
3F5M. The AMP is shown as spheres with grey carbons. Graphic
created with The PyMOL Molecular Graphics System (version
1.8.6.2, Schr€odinger, LLC, New York, NY, USA).
Fig. 4. AMP binding site in Trypanosoma brucei PFK (TbPFK) and
Leishmania infantum PFK (LiPFK). The X-ray structure of the AMP
binding site in TbPFK is shown with AMP coloured grey. Green
and magenta residues are from different TbPFK monomers.
Hydrogen bonds between AMP and TbPFK are shown as yellow
dashed lines. An L. infantum PFK model was threaded onto the
TbPFK template. Yellow residues indicate L. infantum-specific
changes. Black dashes show the modelled hydrogen bond
interactions from (Li)Arg157 to (PO4)
2. The corresponding residue
in LiPFK (Thr159) does not make favourable hydrogen bonds to
AMP in the crystal (orange dashed lines > 4 A). Graphic created
with The PyMOL Molecular Graphics System (version 1.8.6.2,
Schr€odinger, LLC).
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neither the 4 Leishmania nor 4 Trypanosoma have con-
served amino acids). Interestingly, the region that
shows the most obvious differences between the Leish-
mania and Trypanosoma sequences are residues 458–
486 that define the C-terminal helical ‘reaching arm’
previously identified as playing a key role in stabilizing
the tetramer and regulating the T-to-R allosteric tran-
sition [6,32]. Figure S1 shows that the ‘reaching arm’
helix has evolved differently in Trypanosoma species
compared to Leishmania species. In the Leishmania
group 76% of amino acids in the helix are conserved,
but only 25% are conserved within the Trypanosoma
group (with 14% being fully conserved between Leish-
mania and Trypanosoma).
Comparison of the Trypanosoma and Leishmania
sequences (Fig. S1) also reveals differences in the ‘em-
bracing arm’ region, comprising residues 44–75, which
has previously been suggested to govern tetramer sta-
bility [6]. A similar pattern of differences in
conservation between the Trypanosoma and Leishma-
nia sequences is observed: 63% of Leishmania group
amino acids are conserved and different from Try-
panosoma residues; only 6% are conserved in Try-
panosoma and different from Leishmania residues; and
31% are conserved between both groups.
Discussion
Previously published results on multiple trypanoso-
matid PFKs are summarized in Table 2. There are
marked variations in reported kinetic parameters, with
differences in the degree and efficiency of the purifica-
tion methods and the conditions used in the activity
assays. In our study, we have used similar purification
protocols and assay conditions, allowing direct com-
parison of kinetic data from the three orthologous
PFKs.
The allosteric mechanism of AMP in
trypanosomatid PFKs
The finding that pre-incubation of TbPFK with ATP
before addition of F6P causes a 50% reduction in
K0.5
F6P suggests that ATP binding primes the PFK tet-
ramer and aids F6P binding. The prebinding of ATP
also seems to be a requirement for the ‘allosteric acti-
vator’ effect of AMP as reduction of K0.5
F6P and an
increased kcat/K0.5 is only observed when ATP is incu-
bated with PFK before adding AMP. These observa-
tions suggest a model (Fig. 6) in which binding of
ATP is key to switching the inactive T-state conformer
to an active R-state. Our additional biophysical data
for ATP binding, namely micromolar Kd measured by
SPR (Table 4), a large increase in Tm (Fig. S4) and an
ordering of the ‘embracing and reaching’ arms
observed in the crystal structure (PDB 3F5M), all sup-
port this model. AMP binding to PFK mirrors the
ATP data: Kd values (in the absence of ATP) are in
the low millimolar range (Table 3); there are increases
in Tm of 6–9 °C (Fig. S4) and there is ordering of the
embracing and reaching arms observed in the crystal
structure (this work).
The kinetic data (Table 3) suggest that AMP bind-
ing has similar characteristics to an ‘uncompetitive
inhibitor’ which reduces both substrate Kd and Vmax
(Table 3). Also in common with uncompetitive inhibi-
tors, AMP can only show an effect on enzyme activity
once the ATP-PFK (E-S) complex has formed. Given
the large increase in Tm upon AMP binding, we specu-
late that the reduction in both K0.5 and Vmax caused
by AMP binding is a result of the rigidification of the
tetramer: ordering of the ‘reaching and embracing’
Fig. 5. Model of LiPFK based on the X-ray structure of
Trypanosoma brucei PFK (TbPFK). The view is along the twofold
axis relating Dimer 1 to Dimer 2. Dimer 1 is coloured green and
magenta and Dimer 2 orange and yellow. AMP is shown as
spheres within each monomer–monomer interface. Arg157 is
shown as thick sticks with cyan carbons. Residues adjacent to
Arg157 and found within the dimer–dimer interface are shown as
thick sticks with black carbons. The long helical ‘reaching’ arms are
shown as slightly transparent and form a lid over the AMP sites
and stretch across the dimer–dimer interface. Graphic created with
The PyMOL Molecular Graphics System (version 1.8.6.2,
Schr€odinger, LLC).
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arms leading to a better-formed substrate binding site
(giving lower K0.5 values) and possibly slower product
off rate (leading to a lower Vmax). Comparing the
action of AMP to that of an ‘uncompetitive inhibitor’
may appear to contradict its role as an allosteric acti-
vator; however, the parasite PFKs will be operating
under physiological conditions and AMP will indeed
enhance rate when substrate concentrations are around
the measured K0.5 values. The reduction of Vmax in the
presence of AMP will only become relevant at much
higher, nonphysiological values of substrate.
How can the enhanced allosteric action of AMP
in LiPFK be explained?
In the light of the sequence analysis showing that most
of the sequence differences between the Leishmania
and Trypanosoma species are in the stabilizing ‘reach-
ing arm’ and ‘embracing arm’ regions, it is reasonable
to suggest that these differences explain the striking
(> 15 °C) lowering of melting temperature of LiPFK
compared with the two Trypanosoma PFKs. The three
available structures (apo, ATP-bound and AMP-
bound) also show that addition of ATP or AMP has a
dramatic effect on ordering these two (‘reaching and
embracing’) regions. The rise in melting temperature
on addition of these ligands (6–9 °C for AMP and 4–
6 °C for ATP) is also consistent with the observed
increase in secondary structure and enhanced inter-
chain interactions in the tetramer. The kinetic data for
trypanosomatid PFKs fit with the standard allosteric
model for the tetramer which transitions from an
inactive ‘T-state’ conformation (apo structure PDB
2HIG with disordered stabilizing regions) to an active
R-state conformation (more similar to the AMP or
ATP-bound structures). Compared with the Try-
panosoma PFKs, the low-melting LiPFK protein will
favour the partially disordered and inactive T-state
which requires the stabilizing effect of AMP (dispro-
portionally more than the higher melting Trypanosoma
PFKs) before it can adopt the R-state conformation.
The regulatory roles of trypanosomatid PFKs in
glycolysis
Metabolic control analysis studies with bloodstream-
form T. brucei show that PFK has no detectable flux
control; its activity is in excess compared to most of
the other enzymes (except of hexokinase) [33]. If this is
also the case for other trypanosomatid species, it could
be argued that the Trypanosomas have evolved to
remove all flux control from PFK, irrespective of the
F6P concentration in the cell. In contrast, Leishmania
PFK (which is up to 15-fold less efficient than the Try-
panosoma PFKs) may control flux at low F6P concen-
trations, but this control may be released under certain
conditions by increasing the glycosomal AMP concen-
tration. Such a regulatory mechanism may be linked
with the ability of Leishmania spp. amastigotes resid-
ing in the phagosomes of macrophages to enter a
metabolically quiescent state, thought to minimize
immune activation [34]. Intracellular Leishmania
amastigotes rely on glycolysis for their ATP produc-
tion [27]. The ability to downregulate the activity of a
+F6P+F6P
+ATP +AMP
ApoPFK ATP-bound PFK
Part primed
ATP/AMP-bound 
Primed and locked
+F6P
Fig. 6. Proposed model for sequential
substrate and allosteric AMP binding by
trypanosomatid PFKs. ApoPFK has low
affinity for fructose 6-phosphate (F6P)
(green squares) in the absence of ATP (red
circles). When ATP is bound to PFK, the
enzyme becomes part primed and binds
F6P with medium affinity. ATP-bound PFK
permits avid binding of AMP (blue circles),
allowing the enzyme to become primed and
locked, with high affinity for F6P.
10 The FEBS Journal (2020) ª 2019 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
Divergence of PFK regulation among trypanosomatids P. M. Fernandes et al.
glycolytic enzyme like PFK to switch from replicating
to dormant amastigotes and vice versa, dependent on
conditions and/or escape into the macrophage’s cyto-
sol, would thus makes sense. Direct measurements of
adenine nucleotide concentrations in glycosomes are
technically difficult, but models predict
[AMP] < [ADP] < [ATP] [30]; thus, AMP concentra-
tions are a more sensitive indicator of low-energy
states than other nucleotide concentrations. Another
consequence of the strong F6P-dependent activity reg-
ulation by AMP may be that at low glycosomal AMP
concentration, a major proportion of hexoses con-
sumed may be rerouted away from glycolysis to the
pentose-phosphate pathway.
The evolution of Trypanosomatidae PFKs
A genome-wide analysis of evolution of the Try-
panosomatidae family suggests a split between the lin-
eages leading to the Trypanosoma and Leishmania
genera occurred about 120 million years ago [22,23].
Our sequence analysis (Fig. S1) shows that residues
forming both ‘reaching arms’ and ‘embracing arms’
(responsible for stabilizing the PFK tetramer) are
much better conserved between the four Leishmania
species than between the equivalent stabilizing regions
of the four Trypanosoma species. These sequence dif-
ferences correlate with the lower stability (lower Tm)
measured for Leishmania PFK and provide a rationale
for the different allosteric effect of AMP on enzyme
kinetics of Leishmania and Trypanosoma PFKs. The
greater divergence from the common ancestral PFK
sequence by Trypanosoma species strongly suggests
that AMP regulation was present in the early common
ancestor of the two genera but that the Trypanosoma
branch has a lesser need for this regulatory mechanism
while during the course of evolution Leishmania PFKs
have retained AMP regulation.
Are differences in AMP-regulated activity
between Leishmania and Trypanosoma
consistent with parasite environment?
Leishmania lives intracellularly in macrophages and is
therefore only exposed to low glucose levels (only try-
pomastigote forms being present extracellularly in ver-
tebrate hosts during short periods may encounter high
glucose concentrations). In its insect vector, the sand-
fly, it will only occasionally have access to sugars.
Nonetheless, expression of glycosomal glycolytic
enzymes is not downregulated; their protein levels are
even slightly increased [35] and our data suggest that
AMP may play an important role in regulating this
pathway. At high AMP concentrations, LiPFK will
have high activity irrespective of the F6P concentra-
tion; however, at low AMP concentrations, LiPFK
will be much less active.
Although T. cruzi amastigotes are also known to be
capable of entering into a dormant stage during a
chronic phase of Chagas disease [36], they seem to fol-
low a different strategy than Leishmania. Intracellular
T. cruzi reside in the host cell’s cytosol where the con-
centration of glucose and other sugars is very low.
They do not rely on glucose [26] and differ from Leish-
mania amastigotes in that expression of their glycolytic
enzymes is repressed [37], suggesting less need for
activity regulation of the enzymes, T. brucei differs
from T. cruzi and Leishmania spp. by living extracellu-
larly throughout its life cycle, during which it encoun-
ters abundant glucose in the mammalian bloodstream,
but hardly any in the intestinal tract of the tsetse fly,
except for very short periods after the insect has taken
a bloodmeal. This is reflected in high expression of gly-
colytic enzymes in the bloodstream form, whereas
expression of many of the enzymes is considerably
downregulated in the procyclic insect form [38].
Nonetheless, glucose appears to be preferred as sub-
strate over amino acids by procyclic forms when glu-
cose is available, even at low concentration [39].
Glycolytic flux in bloodstream and procyclic forms
does not appear to be regulated by allosteric activators
or inhibitors for any of the enzymatic steps [33,40].
These observations on T. brucei and those mentioned
above for T. cruzi are consistent with our finding that
in Trypanosoma activity regulation of PFK by AMP is
minimal; glycolysis is active at a wide range of F6P
concentrations, irrespective of AMP concentration and
gluconeogenesis will therefore only be favoured at very
low F6P concentrations. Thus, Trypanosoma still pre-
fers the use of glucose for ATP production, even when
the glucose supply is low and gluconeogenic substrates
(amino acids, glycerol) that can also be used for ATP
production are abundantly present, notably in its
insect vectors.
AMP acts as a switch between glycolysis and
gluconeogenesis for Leishmania
Interestingly, the gluconeogenic enzyme fructose-1,6-
bisphosphatase (FBPase) (EC 3.1.3.11) is regulated dif-
ferently in the different kinetoplastid families. This
enzyme, which like PFK is in glycosomes, carries out
the reverse reaction to PFK (converting F16BP to
F6P + Pi). It is present in both life-cycle stages of
T. brucei. No FBPase activity is found in lysates of
glucose-grown bloodstream-form trypanosomes,
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strongly suggesting that it is regulated by post-transla-
tional modification (PM, unpublished data). Previ-
ously, we reported that leishmanial FBPase is strongly
regulated by AMP – but in the opposite direction to
PFK – with rising concentrations of AMP inhibiting
gluconeogenesis (IC50 63.8 µM for Leishmania major
FBPase) [41]. Our data presented here on the activa-
tion of LiPFK by AMP, combined with the previously
published data on AMP inhibition of LmFBPase,
strongly imply that in Leishmania, AMP plays a role
in controlling the balance between glycolysis and glu-
coneogenesis with AMP concentration providing a
switching mechanism that can simultaneously shut
down gluconeogenesis and upregulate glycolysis. As
we have shown here, AMP is a much less efficient acti-
vator of Trypanosoma than Leishmania PFK. It is rea-
sonable to suggest that sensitivity of the AMP-
regulated switch to adjust the glycolytic flux to glucose
availability in Leishmania, as well as to govern the bal-
ance between glycolysis and gluconeogenesis, is an
important factor in the evolutionary divergence of
Leishmania and Trypanosoma that is consistent with
their different biological niches.
Materials and methods
Recombinant trypanosomatid PFKs were expressed in
E. coli and purified using the method described previously
[42]; full sequence alignments are shown in Fig. S1.
Determination of kinetic characteristics using
pyruvate kinase–lactate dehydrogenase enzyme-
linked kinetic assay
Kinetic values for PFK were determined using an in vitro
assay connecting ADP production to NADH oxidation
(measurable with UV absorbance at A340nm) through pyru-
vate kinase and then lactate dehydrogenase.
Assay buffer consisted of 50 mM TEA, 100 mM KCl,
10 mM MgCl2 and 10% glycerol, pH 7.4. Assay mix con-
sisted of 1.2 mM NADH (Sigma-Aldrich N4505, Gilling-
ham, Dorset, UK), 33 unitsmL1 lactate dehydrogenase
(Sigma-Aldrich L1254), 4.8 mM phosphoenolpyruvate
(P0564) and 20 unitsmL1 human M1 pyruvate kinase in
assay buffer (expressed and purified from E. coli in the
Edinburgh Protein Production Facility, University of Edin-
burgh). ATP and F6P were obtained from Sigma-Aldrich
(A2383 and F3627, respectively). Trypanosomatid PFKs
were added to the assay mix, at final concentrations of
4 lgmL1 for TcPFK and TbPFK and 8.7 lgmL1 for
LiPFK (higher enzyme concentrations were required for
LiPFK experiments due to lower intrinsic activity). All
ligands and substrates (including ATP) were used at pH
7.4. All metabolites were obtained from Sigma-Aldrich,
including AMP (O1930) and GTP (G8877).
Forty microlitre assay mix with PFK was added to a clear
nonbinding 96-well plate. Twenty microlitre of ATP was
added, to give a final concentration of 1.5 mM. Alternatively,
20 lL of ATP titration was added, to give final concentra-
tions of 2.5 mM downwards (8–12 serial 50% dilutions).
Twenty microlitre of ligand (final concentration stated in
text) or buffer was added, and the plate was incubated at
25 °C for 5 min. F6P was added last, to start the reaction,
with 20 lL of F6P (final concentration 3 mM) or F6P titra-
tion, to give final concentrations of 5 mM downwards (8–12
serial 50% dilutions). Reaction order was kept constant
unless otherwise stated. Concentration of NADH, assessed
via A340nm, was measured at 12-s intervals for 10 min using a
SpectraMax M5 Multi-Mode Microplate Reader.
The Beer–Lambert law was used to convert time-depen-
dent absorbance change into rate of NADH oxidation
(lMs1) or specific activity (lmolmin1mg protein1),
using NADH’s molar extinction coefficient of
6.22 mM1cm1. Reaction rates were calculated using a 4-
point (48 s) rolling average. GraphPad Prism 7 was used
for data analysis. Kinetic properties were determined using
nonlinear regression analysis of substrate titration data to
generate curves fitted using allosteric sigmoidal model cal-
culated using the following equation:
V0 ¼ Vmax X
h
Xh þ Khm
 
:
Surface plasmon resonance (SPR) assays for
measuring analyte binding to trypanosomatid
PFKs
Sensor chip surfaces with active N-terminal His6-tagged
T. brucei, T. cruzi and L. infantum PFK were generated by
using a capture/stabilization method [43,44]. Surface densi-
ties corresponding to 1400–3200 resonance units (RU) were
immobilized on Ni2+-nitrilotriacetic acid sensor chips (GE
Healthcare, GE Healthcare Life Sciences, Little Chalfont,
Buckinghamshire, UK). Substrates and other metabolic
analytes were made up and buffered in HBS buffer (10 mM
HEPES, 150 mM NaCl, 10 mM MgCl2, 0.05% Tween-20,
pH 7.4). The following analytes were made up in 2.5-fold
serial dilutions over concentration ranges 10 mM to 7.8 µM:
AMP, ADP, ATP, GTP, GDP, F6P, F16BP; concentration
ranges 20 mM to 156 µM were used for citrate, inorganic
pyrophosphate, phosphoenolpyruvate. Analytes were
washed over the surfaces at a rate of 30 µLmin1 with 30-
second contact time and washed off with HBS buffer for
30 s. When analytes were tested in the presence of AMP or
ATP, these analytes were added to a concentration of
1 mM to the HBS running buffer and all analyte dilution
series were made up in this buffer. All values were
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calculated from plots of steady-state responses versus con-
centration using analysis software (v2.02) provided with the
BIAcore T200 instrument (GE Healthcare).
Thermal denaturation measurements of
trypanosomatid PFK
Thermal denaturation assays (TDA) were carried out to
assess the thermal stability of the trypanosomatid PFKs. A
real-time PCR instrument was used (Bio-Rad iQTM5 iCycler,
Bio-Rad Laboratories, Ltd. Watford, UK) to heat the PFK
samples from 20 to 80 °C in the presence of a fluorescent dye
– ‘SYPRO Orange’ (Sigma). Upon denaturation of the pro-
tein, the SYPRO Orange dye binds the exposed hydrophobic
regions, and the increase in fluorescent signal (ex/em = 485/
575 nm) is measured in relative fluorescence units (RFU).
The transition melting temperatures (Tm values) of
T. brucei, T. cruzi and L. infantum PFKs were determined
using the same TEA-based buffer (10 mM MgCl2, 100 mM
KCl, 50 mM TEA, 10% glycerol, 0.005% Tween, pH 7.4).
50-µL reactions containing 1.9 µM PFK were heated with
0.5 °C increments from 4 to 80 °C in the presence of
SYPRO Orange.
Crystallization and structure determination and
model building
Purified T. brucei PFK in gel filtration buffer containing
1 mM F16BP, 1 mM AMP and 500 µM novel PFK inhibitor
[32] was concentrated to 6 mgmL1 and crystallized via
hanging drop methods at 18 °C. The well solution con-
sisted of 9.5% PEG 8000 and 0.1 M sodium cacodylate at
pH 7.4. Drops were set up containing 1 µL protein solu-
tion, 1.5 µL well solution and 0.5 µL silver bullet 23
(Hampton Research, 0.25% w/v 1,2-diaminocyclohexane
sulfate, 0.25% w/v 1,4-cyclohexanedicarboxylic acid, 0.25%
w/v methylenediphosphonic acid, 0.25% w/v sulfanilic acid
and 0.02 M HEPES sodium, pH 6.8). Data were collected
on beamline I04-1 at the Diamond synchrotron radiation
facility. The intensity data were collected from single crys-
tals flash-frozen in liquid nitrogen at 100 K. Data were
processed with XDS and AIMLESS [45]. Initial phases
were obtained by molecular replacement using the program
PHASER [46] and 3F5M as the search model. Refinement
was performed with the program REFMAC utilizing local
NCS restraints. Manual adjustment was performed using
the program COOT [47] as part of the CCP4 program suite
[48], and data collection and refinement statistics are shown
in Table S1. Noncrystallographic restraints were not
applied during refinement and each of the eight PFK
chains in the asymmetric unit was refined independently.
Although crystallization was performed in the presence of
AMP, F16BP and novel PFK inhibitor, only density for
AMP could be identified and modelled. A small amount of
unidentified density was found near the ATP binding site
and has been modelled with a benzene ring. A lower resolu-
tion (3.5 A) structure (data not shown) with only AMP
bound in the effector site has an RMSD of less than 0.6 A
to the structure presented here; thus, we can be confident
that this structure and its allosteric movement are a reflec-
tion solely of the binding of AMP to TbPFK without sig-
nificant influence of the inhibitor or F16BP. A model for
LiPFK was produced using the Phyre2 Web portal [49] and
its one-to-one threading mode. The AMP structure
described here was used as the input model.
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